Stay updated on ED-SCLC Immuno-Therapy Clinical Trial
Sign up to get notified when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.

Latest updates to the ED-SCLC Immuno-Therapy Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status has been updated to indicate that no participants are being enrolled, signaling that enrollment is closed. The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment label along with a revision tag.SummaryDifference0.2%

- Check8 days agoChange DetectedAdded Lung cancer as a topic and a related topics section, including a MedlinePlus Genetics reference. Updated the revision tag from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page loses certain background topic labels and the MedlinePlus Genetics link, reducing some background resources while keeping the study details and structure intact.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a new version of the page content.SummaryDifference0.0%

- Check44 days agoChange DetectedAn updated study site listing appears as Taoyuan, Taiwan, 333, and the Taoyuan District listing is removed; the page also adds Lung cancer as a topic and includes related topics such as MedlinePlus Genetics.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page footer now shows an updated system/version label (“Revision: v3.5.3”). Related topic text in the surrounding MedlinePlus/links area was adjusted, without changing the study’s core details.SummaryDifference0.1%

Stay in the know with updates to ED-SCLC Immuno-Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ED-SCLC Immuno-Therapy Clinical Trial page.